Surrey Heartlands

Joint Formulary & PAD

Mometasone furoate - Inflammatory skin conditions

You are here : Home > Formulary Search > Mometasone furoate - Inflammatory skin conditions

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Cream
  • Ointment
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
SPC
Restrictions / Comments :
Important

0.1% potent

 

Status 2

Green
Formulations :
  • Scalp application
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
SPC
Restrictions / Comments :
Important

0.1% scalp lotion

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Mometasone furoate
Indication :
Inflammatory skin conditions
Group Name :
Keywords :
psoriasis, dermatitis, pruritis, eczema, topical corticosteroids
Brand Names Include :
Elocon
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
2

Committee Recommendations (1)

03 May 17 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
Mometasone furoate (topical) has been considered by the PCN and has been assigned a GREEN traffic light status, within its LICENSED indication(s).

NOTE - the branded product (Elcon) was considered BLACK at the PCN in May 2017.

Other Indications

Below are listed other indications that Mometasone furoate is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Inflammatory skin conditions.